Shares of Incyte stock opened at $60.60 on Friday. The company has a 50-day simple moving average of $69.53 and a two-hundred day simple moving average of $70.04. Incyte has a 52-week low of $50. ...

Spider-Man 4 will be a "fresh start" for Peter Parker, according to star Tom Holland, so forget everything you know about the character and get ready for a brand-new MCU adventure. The film, which ...

Fintel reports that on March 18, 2025, William Blair downgraded their outlook for Incyte (BMV:INCY) from Outperform to Market Perform. There are 1,211 funds or institutions reporting positions in ...

There are two Collection Challenges available in Pokémon Go during the Deep Depths event, and one of them is called Sea-volution. You’ll be focusing on the Water-based Pokémon that will appear ...

Incyte (NASDAQ:INCY) recently announced that it had achieved positive results from both of its phase 3 studies STOP-HS1 and STOP-HS2. Both of these late-stage studies were using the company's drug ...

Shares of Incyte INCY were down 8.62% on Monday after the announcement of data from two late-stage studies on an oral small-molecule JAK1 inhibitor, povorcitinib, for the treatment of hidradenitis ...

Wells Fargo analyst Derek Archila maintained a Hold rating on Incyte (INCY – Research Report) yesterday and set a price target of $58.00. The company’s shares closed yesterday at $62.01.

Shares of biopharmaceutical company Incyte Corporation (NASDAQ:INCY) fell 15.2% in the pre-market session after the company released phase three trial data for a skin condition treatment ...

Spider-Man is one of the few Marvel heroes with a supporting cast and rogues gallery wide enough to support an entire cinematic universe. Or so execs at Sony thought when they launched their ...